Single-Use Bioreactors Market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR of 19.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as the increasing adoption of single-use bioreactors among startups and SMEs, lower operational complexity of single-use bioreactors compared to conventional stainless-steel bioreactors, reduced energy and water consumption, growing size of the biologics and biosimilars market, and technological advancements in single-use bioreactors.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
The global single-use bioreactors market is consolidated, with Sartorius AG (Germany), Danaher Corporation (US), and Thermo Fisher Scientific Inc. (US) together holding a major share of the global market
Sartorius AG (Germany) is one of the leading players in the global single-use bioreactors market. The company’s strong focus on a broad range of customers, technology-enabled solutions, and investments in collaborations & partnerships contribute to the growth of the company’s market share.
Danaher Corporation (US) is a global top player in the single-use bioreactors market. Pall Corporation and Cytiva are two of the company’s subsidiaries through which it offers single-use bioreactors market products.
The monoclonal antibodies segment accounted for the largest share of the type of molecule segment in the single-use bioreactors market
Based on the type of molecule, the global single-use bioreactors market is segmented into monoclonal antibodies (mAbs), vaccines, gene-modified cells, stem cells, and other molecules. The monoclonal antibodies segment accounted for the largest share of the global single-use bioreactors market owing to increasing demand for single-use bioreactors in the manufacturing of mAbs, and factors such as low investment costs and a reduction in time-intensive changeover procedures.
The mammalian cells segment accounted for the fastest growing share of the type of cell segment in the single-use bioreactors market
Based on the type of cell, the global single-use bioreactors market is segmented into mammalian cells, bacterial cells, yeast cells, and other cells. the mammalian cells segment accounted for the largest share of the market owing to increasing adoption of mammalian cells due to their post-translational modification capacity and human protein-like molecular structure assembly are expected to propel market growth.
Inquire Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=49113750
The Asia Pacific region is the fastest-growing region of the single-use bioreactors market
The Asia Pacific market is expected to register the highest CAGR during the forecast period. Factors such as the growing biopharmaceutical industry, rising investments by pharmaceutical & biotechnology companies, and the growing number of CROs & CMOs in several Asia Pacific countries are supporting the growth of the market in the region.
This report categorizes the single use bioreactors market to forecast revenue and analyze trends in each of the following submarkets:
By Product
single use bioreactor systems
- Up to 10 L
- 11–100 L
- 101–500 L
- 501–1500 L
- Above 1500 L
- single use media bags
- 2D Bags
- 3D Bags
- Other bags
- single use filtration assemblies
- Other products
By Type of Molecule
- Stirred-tank single use bioreactors
- Wave-induced single use bioreactors
- Bubble-column single use bioreactors
- Other single use bioreactors
By Type of Cell
- Mammalian cells
- Bacterial cells
- Yeast cells
- Other cells
By Application
- Bioproduction
- Process development
- Research & development
By End User
- Pharmaceutical & biotechnology companies
- CROs & CMOs
- Academic & research institutes
By Region
- North America
- Europe
- Asia Pacific (APAC)
- Latin America (LATAM)
- Middle East and Africa (MEA)
Buy Single-Use Bioreactors Industry Research report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=49113750
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
